A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets
Antonio Atalaia,
Rachel Thompson,
Alberto Corvo,
Leigh Carmody,
Davide Piscia,
Leslie Matalonga,
Alfons Macaya,
Angela Lochmuller,
Bertrand Fontaine,
Birte Zurek,
Carles Hernandez-Ferrer,
Carola Reinhard,
David Gómez-Andrés,
Jean-François Desaphy,
Katherine Schon,
Katja Lohmann,
Matthew J. Jennings,
Matthis Synofzik,
Olaf Riess,
Rabah Ben Yaou,
Teresinha Evangelista,
Thiloka Ratnaike,
Virginie Bros-Facer,
Gulcin Gumus,
Rita Horvath,
Patrick Chinnery,
Steven Laurie,
Holm Graessner,
Peter Robinson,
Hanns Lochmuller,
Sergi Beltran,
Gisèle Bonne
Aug 12, 2021
Abstract: Background: Rare diseases are individually rare but globally affect around 6% of the population, and in over 70% of cases are genetically determined. Their rarity translates into a delayed diagnosis, with 25% of...